Recruiting studies: Psa Progression

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prost
NA · 3 location(s) · Norwegian University of Science and Technology · NCT07422597 MRI-Assisted Guidance for Non-Essential Tissue Sampling
NA · 1 location(s) · Shanghai East Hospital · NCT07516223 Upright MRI for Prostate Cancer Screening
Phase N/A · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT03474913 PSMA PET Combined With MRI for the Detection of PCa
Phase 3 · 18 location(s) · Telix Pharmaceuticals (Innovations) Pty Limited · NCT07052214 Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA
Phase 1/Phase 2 · 1 location(s) · Milton S. Hershey Medical Center · NCT06600698 Working Out M0 Bipolar Androgen Therapy
Phase 2 · 12 location(s) · Australian and New Zealand Urogenital and Prostate Cancer Tr · NCT06594926 Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Underg
NA · 1 location(s) · National Cancer Institute (NCI) · NCT04692675 Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)
Phase 2 · 12 location(s) · Fundacion Oncosur · NCT06582628 Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS)
Phase N/A · 1 location(s) · Northwestern University · NCT06804785 Oxidative Stress in Autoimmune Rheumatic Diseases
Phase N/A · 1 location(s) · University of Thessaly · NCT07536529 The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
Phase 3 · 33 location(s) · Telix Pharmaceuticals (Innovations) Pty Limited · NCT06520345 PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence
Phase 2 · 1 location(s) · AdventHealth · NCT06617481

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.